Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9531074, 8 pages
https://doi.org/10.1155/2017/9531074
Research Article

Cytoplasmic Localization of WT1 and Decrease of miRNA-16-1 in Nephrotic Syndrome

1Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León (UANL), 66450 San Nicolás de los Garza, NL, Mexico
2Laboratorios de Inmunología y Biología Molecular, Unidad Académica de Ciencias Biológicas, Universidad Autónoma de Zacatecas (UAZ), 98040 Zacatecas, ZAC, Mexico
3Hospital General Zacatecas “Luz González Cosío”, Ciudad Gobierno, 98160 Zacatecas, ZAC, Mexico

Correspondence should be addressed to Pablo Zapata-Benavides; moc.liamtoh@atapazolbap

Received 11 September 2016; Revised 9 January 2017; Accepted 23 January 2017; Published 19 February 2017

Academic Editor: Jae I. Shin

Copyright © 2017 Pablo Zapata-Benavides et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Macé and S. S. Chugh, “Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics,” Journal of the American Society of Nephrology, vol. 25, no. 11, pp. 2393–2398, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Bierzynska, K. Soderquest, and A. Koziell, “Genes and podocytes—new insights into mechanisms of podocytopathy,” Frontiers in Endocrinology, vol. 5, article no. 226, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Lasagni and P. Romagnani, “Basic research: podocyte progenitors and ectopic podocytes,” Nature Reviews Nephrology, vol. 9, no. 12, pp. 715–716, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Sinha and A. Bagga, “Nephrotic syndrome,” Indian Journal of Pediatrics, vol. 79, no. 8, pp. 1045–1055, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Sekulic and S. Pichler Sekulic, “A compendium of urinary biomarkers indicative of glomerular podocytopathy,” Pathology Research International, vol. 2013, Article ID 782395, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Zhou, H. Kajiyama, T. Tsuji et al., “Urinary exosomal wilms' tumor-1 as a potential biomarker for podocyte injury,” American Journal of Physiology - Renal Physiology, vol. 305, no. 4, pp. F553–F559, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Bariety, C. Mandet, G. S. Hill, and P. Bruneval, “Parietal podocytes in normal human glomeruli,” Journal of the American Society of Nephrology, vol. 17, no. 10, pp. 2770–2780, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. H. Yang, F. Zhao, D. N. Feng et al., “Wilms' tumor suppressor gene mutations in girls with sporadic isolated steroid-resistant nephrotic syndrome,” Genetics and Molecular Research, vol. 12, no. 4, pp. 6184–6191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. D. N. Feng, Y. H. Yang, D. J. Wang et al., “Mutational analysis of podocyte genes in children with sporadic steroid-resistant nephrotic syndrome,” Genetics and Molecular Research, vol. 13, no. 4, pp. 9514–9522, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Beltcheva, A. Boueva, E. Morgunova et al., “Novel mutation in Wilms' tumour 1 gene associated with steroid-resistant nephrotic syndrome,” NDT Plus, vol. 4, no. 1, pp. 17–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Mucha, F. Ozaltin, B. G. Hinkes et al., “Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9,” Pediatric Research, vol. 59, no. 2, pp. 325–331, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-M. Gao, C.-Y. Xing, C.-Q. Chen, S.-S. Lin, P.-H. Dong, and F.-J. Yu, “MiR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level,” Journal of Experimental & Clinical Cancer Research, vol. 30, no. 1, article 110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Hou and D. Zhao, “MicroRNA regulation in renal pathophysiology,” International Journal of Molecular Sciences, vol. 14, no. 7, pp. 13078–13092, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. C.-K. Chung and H. Y. Lan, “MicroRNAs in renal fibrosis,” Frontiers in Physiology, vol. 6, article no. 50, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Wang, Z. Hu, and L. Chen, “Decreased serum miR-503 level in children with nephrotic syndrome,” Clinical Laboratory, vol. 61, no. 12, pp. 1917–1926, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Rudnicki, P. Perco, B. D'haene et al., “Renal microRNA- and RNA-profiles in progressive chronic kidney disease,” European Journal of Clinical Investigation, vol. 46, no. 3, pp. 213–226, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Tiberio, M. Callari, V. Angeloni, M. G. Daidone, and V. Appierto, “Challenges in using circulating miRNAs as cancer biomarkers,” BioMed Research International, vol. 2015, Article ID 731479, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Ramezani, J. M. Devaney, S. Cohen et al., “Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study,” European Journal of Clinical Investigation, vol. 45, no. 4, pp. 394–404, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. S.-M. Gao, J.-J. Yang, C.-Q. Chen et al., “Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells,” Journal of Experimental and Clinical Cancer Research, vol. 31, no. 1, article no. 27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. C. A. Gebeshuber, C. Kornauth, L. Dong et al., “Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1,” Nature Medicine, vol. 19, no. 4, pp. 481–487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Li, A. C. K. Chung, X. Yu, and H. Y. Lan, “MicroRNAs in diabetic kidney disease,” International Journal of Endocrinology, vol. 2014, Article ID 593956, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Kato, S. Mizuno, and M. Kamimoto, “The decreases of nephrin and nuclear WT1 in podocytes may cause albuminuria during the experimental sepsis in mice,” Biomedical Research, vol. 31, no. 6, pp. 363–369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. K. W. Dunn, M. M. Kamocka, and J. H. McDonald, “A practical guide to evaluating colocalization in biological microscopy,” American Journal of Physiology—Cell Physiology, vol. 300, no. 4, pp. C723–C742, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Sui, H. Lin, H. Li, Q. Yan, J. Chen, and Y. Dai, “Circulating microRNAs as potential biomarkers for nephrotic syndrome,” Iranian Journal of Kidney Diseases, vol. 8, no. 5, pp. 371–376, 2014. View at Google Scholar · View at Scopus
  25. J. L. Te, I. M. Dozmorov, J. M. Guthridge et al., “Identification of unique MicroRNA signature associated with lupus nephritis,” PLoS ONE, vol. 5, no. 5, Article ID e10344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT–PCR,” Nucleic Acids Research, vol. 29, no. 9, article e45, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. E. M. Hodson, N. S. Willis, and J. C. Craig, “Corticosteroid therapy for nephrotic syndrome in children,” Cochrane database of systematic reviews (Online), no. 4, p. CD001533, 2007. View at Google Scholar · View at Scopus
  28. S. N. Uwaezuoke, “Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis,” Italian Journal of Pediatrics, vol. 41, article no 19, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Niaudet, “Steroid-resistant idiopathic nephrotic syndrome in children,” in Pediatric Nephrology, E. D. Avner, W. E. Harmon, and P. Niaudet, Eds., vol. 2004, pp. 557–574, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2004. View at Google Scholar
  30. J. J. Bollain, M. González, F. Torres et al., “Increased excretion of urinary podocytes in lupus nephritis,” Indian Journal of Nephrology, vol. 21, no. 3, pp. 166–171, 2011. View at Publisher · View at Google Scholar
  31. H. Ohsaki, T. Sofue, K. Kawakami et al., “WT1 immunoenzyme staining using SurePath™ processed urine cytology helps to detect kidney disease,” Cytopathology, vol. 27, no. 1, pp. 43–49, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Barutta, M. Tricarico, A. Corbelli et al., “Urinary exosomal MicroRNAs in incipient diabetic nephropathy,” PLoS ONE, vol. 8, no. 11, Article ID e73798, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Zhou, H. Kajiyama, T. Tsuji et al., “Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury,” American Journal of Physiology—Renal Physiology, vol. 305, no. 4, pp. F553–F559, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Joshi, R. Andersen, B. Jespersen, and S. Rittig, “Genetics of steroid-resistant nephrotic syndrome: a review of mutation spectrum and suggested approach for genetic testing,” Acta Paediatrica, International Journal of Paediatrics, vol. 102, no. 9, pp. 844–856, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. G. Ruf, M. Schultheiss, A. Lichtenberger et al., “Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome,” Kidney International, vol. 66, no. 2, pp. 564–570, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-K. Guo, A. L. Menke, M.-C. Gubler et al., “WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis,” Human Molecular Genetics, vol. 11, no. 6, pp. 651–659, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Siehl, E. Thiel, K. Heufelder et al., “Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias,” British Journal of Haematology, vol. 123, no. 2, pp. 235–242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. R. I. Aqeilan, G. A. Calin, and C. M. Croce, “MiR-15a and miR-16-1 in cancer: discovery, function and future perspectives,” Cell Death and Differentiation, vol. 17, no. 2, pp. 215–220, 2010. View at Publisher · View at Google Scholar · View at Scopus